Please assess the completion status of the following clinical trial:

Trial Title: TDCS for Auditory Hallucinations in Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 18-55~* Structured Clinical Interview for DSM Disorders (SCID) primary diagnosis of DSM-IV (Diagnostic and Statistical Manual of Mental Disorders-Version IV) schizophrenia or schizoaffective disorder~* Persistent auditory verbal hallucinations~* Right handed~* Stable antipsychotic medication for \> 4 weeks~* Normal hearing~* If female and not infertile, must agree to use one of the following forms of contraception for the duration of study participation: systemic hormonal treatment, an interuterine device (IUD) which was implanted at least 2 months prior to screening, or double-barrier contraception~* Willing/capacity to provide informed consent~Exclusion Criteria:~* Substance dependence or abuse (excluding nicotine) in the past 90 days~* Current significant laboratory abnormality~* History of seizure, epilepsy in self or fist degree relatives, stroke, brain surgery, head injury with loss of consciousness \> 1 hour or clear cognitive sequelae, intracranial metal implants, known structural brain lesion, devices that may be affected by transcranial Direct Current Stimulation (tDCS) (pacemaker, medication pump, cochlear implant, implanted brain stimulator)~* Frequent and persistent migraines~* History of adverse reaction to neurostimulation or open skin wounds that would preclude safe placement of tDCS electrodes~* Participation in study of investigational medication/device within 4 weeks~* Current use of medications known to lower seizure threshold (lithium, serotonergic or tricyclic antidepressants)~* If female, pregnant or breast feeding at the time of screening~* For MRI study only: Claustrophobia or metal implants or paramagnetic objects contained within the body which may interfere with the MRI scan, as determined according to the guidelines set forth in the following reference book: Guide to MR procedures and metallic objects Shellock, PhD, Lippincott-Raven press, NY 1998

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Transcranial Direct Current Stimulation (Type: EXPERIMENTAL): Transcranial Direct Current Stimulation (tDCS) treatments will take place for 20 minutes per day for 5 consecutive days
- Sham tDCS (Type: SHAM_COMPARATOR): Sham tDCS(inactive)treatment (transcranial Direct Current Stimulation) will take place for 20 minutes per day for 5 consecutive days.

Based on this trial design, predict the completion outcome and termination type (if applicable).